Glutaric aciduria type 1, also called glutaric acidemia type 1 and abbreviated GA1, is an inherited metabolic disorder in which the body cannot completely break down the amino acids lysine, hydroxylysine and tryptophan. Intermediate products of that breakdown, including glutaric acid, glutaryl-CoA, 3-hydroxyglutaric acid and glutaconic acid, accumulate and can damage the brain, particularly the basal ganglia, the regions that help regulate movement, and other organs as well. Because glutaric acid is detoxified by carnitine, the condition also causes a secondary carnitine deficiency, and intellectual disability may occur. GA1 is inherited in an autosomal recessive pattern and is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, which is encoded by the GCDH gene.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 2 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) Prevalence Band Sources
1. Glutaric aciduria type 1 (Wikipedia)
Lead paragraph 1
can accumulate and cause damage to the brain (and also other organs), but particularly the basal ganglia
Lead paragraph 2
GA1 is an autosomal recessive disorder caused by deficiency of the enzyme glutaryl-CoA dehydrogenase (GCDH), encoded by the GCDH gene.
Lead
Glutaric acidemia type 1 (GA1) is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine and tryptophan.
View the Source2. Orphadata (Orphanet): Orphadata cross-references for ORPHA:25 Glutaric aciduria type 1
Orphadata (Orphanet)ICD-10 cross-referenceQuote, ICD-10 cross-reference
"Reference": "E72.3", "Source": "ICD-10"
View the Source 3. Monarch Initiative: glutaryl-CoA dehydrogenase deficiency - Monarch Initiative MONDO:0009281
Monarch InitiativeDisease descriptionQuote, Disease description
Glutaryl-CoA dehydrogenase (GCDH) deficiency (GDD) is an autosomal recessive neurometabolic disorder clinically characterized by encephalopathic crises resulting in striatal injury and a severe dystonic dyskinetic movement disorder.
View the Source 4. Orphadata (Orphanet): Orphadata epidemiology for ORPHA:25 Glutaryl-CoA dehydrogenase deficiency
Orphadata (Orphanet)Prevalence, WorldwideQuote, Prevalence, Worldwide
"PrevalenceClass": "1-9 / 100 000", "PrevalenceGeographic": "Worldwide"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.